Skip to nav Skip to content

Clinical Trial Search

366 Clinical Trials Found

Clinical Trial 20641

A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma
Disease Site: Melanoma, skin
PI: Eroglu, Zeynep

Clinical Trial 22002

A Multicenter Open-Label Study of RMC-6236 in Patients with Advanced Solid Tumors Harboring Specific Mutations in RAS
Disease Site: Any Site, Liver, Lung, Other Digestive Organ, Pancreas, Small Intestine, Stomach
PI: Kim, Dae Won

Clinical Trial 23659

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Disease Site: Any Site, Cervix, Colon, Corpus Uteri, Lung, Other Female Genital, Pancreas, Rectum
PI: Kim, Richard

Clinical Trial 23777

A Randomized, Masked, Placebo Controlled, Phase II Trial of Concurrent Chemoradiation with BMX-001 in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
PI: Razavian, Niema

Clinical Trial 23976

Single Arm Phase II Study of Bladder Preservation with Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients with Muscle Invasive Bladder Cancer (BRIGHT)
Disease Site: Urinary Bladder
PI: Grass, George (Daniel)

Clinical Trial 23563

A Phase 1b trial of Teclistamab in Combination with Iberdomide for Relapsed/Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
PI: Grajales-Cruz, Ariel

Clinical Trial 23082

Disease Site: Melanoma, skin
PI: Karapetyan, Lilit

Clinical Trial 23182

Disease Site: Lung
PI: Gray, Jhanelle

Clinical Trial 23581

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Tarlatamab in Combination with YL201 with or without Anti-PD-L1 in Subjects with Extensive Stage Small Cell Lung Cancer
Disease Site: Lung
PI: Puri, Sonam

Clinical Trial 23641

Disease Site: Unknown Sites
PI: Pidala, Joseph

Clinical Trial 21192

A Phase 2 Study of the Combination Dostarlimab with Niraparib In Patients with Penile Carcinoma Who Have Progressed Following Chemotherapy
Disease Site: Other Male Genital
PI: Chadha, Juskaran

Clinical Trial 23556

A Phase 1 Study of MLN7243 (TAK-243) for Either Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome/Chronic Myelomonocytic Leukemia Refractory to Hypomethylating Agents
Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS)
PI: Lancet, Jeffrey